CECC confirms 234 more cases of Omicron subvariants, including 174 domestic cases and 60 imported cases

CECC confirms 25,583 more COVID-19 cases, including 25,346 domestic cases and 237 imported cases

CECC confirms 32,128 more COVID-19 cases, including 31,854 domestic cases and 274 imported cases

CECC confirms 35,830 more COVID-19 cases, including 35,594 domestic cases and 236 imported cases

CECC confirms 34,260 more COVID-19 cases, including 34,020 domestic cases and 240 imported cases

First batch of preventative monoclonal antibody therapy Evusheld purchased by CECC to be distributed to provide better protection for individuals with weak immune systems in Taiwan

CECC confirms 35,124 more COVID-19 cases, including 34,846 domestic cases and 278 imported cases

CECC confirms 41,296 more COVID-19 cases, including 41,021 domestic cases and 275 imported cases

CECC confirms 36,707 more COVID-19 cases, including 36,393 domestic cases and 314 imported cases

CECC announces ACIP's recommendations on rollout of Moderna's second-generation bivalent COVID-19 vaccine, booster dose interval, and use of Novavax COVID-19 vaccine in adolescents aged 12-17